---

title: 'Vasopressors and Inotropes in Shock'
authors:
    - 'Michelle Lin, MD'
created: 2010/04/30
updates:
    - 2010/04/30
categories:
    - Cardiovascular
    - 'Critical Care'
drugs: 'epinephrine, Phenylephrine, norepinephrine, dopamine, dobutamine'

---


# Vasopressors and Inotropes in Shock

The treatment of shock should focus on correcting the underlying pathophysiology. With persistent hemodynamic instability, a vasopressor and/or inotrope should be selected. Reviewing receptor physiology can help you select the best-fit agent for the patient's clinical condition.

## Physiologic Categories of Shock

-   **Cardiogenic:**
    -   *Intrinsic disease*: myopathy, AMI, valvular dysfunction, arrhythmia
    -   *Extrinsic disease*: obstructive disorders (PE, pericardial tamponade, tension PTX)
-   **Hypovolemic:** bleeding, diarrhea, burns, third-spacing
-   **Distributive:** sepsis, anaphylaxis, toxic shock syndrome, central neurologic injury

## Receptor Physiology

**Alpha-adrenergic receptors**

-   Alpha-1 agonists cause vasoconstriction
-   Alpha-2 agonists causes vasodilatation esp. of coronary arteries

**Beta-adrenergic receptors**

-   Beta-1 agonists increases HR and cardiac contractility → increased CO
-   Beta-2 agonists dilate small coronary A’s, visceral organ A’s, skeletal muscle A’s and increase bronchodilation

**Dopaminergic receptors**

-   7 types of dopamine receptors.
-   D4 agonists increase cardiac contractility
-   D1 and D2 agonists increase renal diuresis and naturesis

**Vasopressin receptors**

-   V1 agonists cause vasoconstriction mostly in peripheral arterioles

## Medications

**<class span="drug">Epinephrine</span>**

-   Full range of alpha and beta agonist properties
-   Risk of dysrhythmias, AMI, abdominal organ ischemia
-   Dose 2-10 mcg/min mostly increases beta-1 effects
-   Dose &gt;10 mcg/min mostly increases alpha effects

**<class span="drug">Phenylephrine</span>**

-   Pure alpha agonist activity and minimally affects cardiac function directly

**<class span="drug">Norepinephrine</span>**

-   Alpha and beta agonist activity
-   Dose &lt; 2 mcg/min mostly beta-agonist effects
-   Dose &gt; 3 mcg/min adds alpha agonist effects
-   First line agent to improve BP for septic shock

**<class span="drug">Dopamine</span>**

-   Dose 0.5-2 mcg/kg/min stimulates D1 receptors
-   Dose 2-5 mcg/kg/min stimulates norepinephrine release
-   Dose 5-10 mcg/kg/min stimulates beta-1 activity
-   Dose &gt;10 mcg/kg/min stimulates both beta-1 and alpha activity
-   *Surviving Sepsis Campaign* recommends **dopamine** or **norepi** as 1st-line agents

**<class span="drug">Dobutamine</span>**

-   Mainly beta-1 agonist --&gt; increased SV and CO with minimal affect on SVR
-   Less myocardial oxygen consumption

## Vasopressors and inotropes in shock (table)

![](https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/5/m/b05f6e95-0a29-531e-af1f-c4ab1bd445fc/640.png)
From [Ellender TJ, Skinner JC. Emerg Med Clin North Am. 2008](http://www.ncbi.nlm.nih.gov/pubmed/18655944)

## References

-   [Ellender TJ, Skinner JC. Emerg Med Clin North Am. 2008 Aug;26(3):759-86.](http://www.ncbi.nlm.nih.gov/pubmed/18655944)
